These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 15114583)
1. Pseudodynamic combinatorial libraries: a receptor-assisted approach for drug discovery. Corbett AD; Cheeseman JD; Kazlauskas RJ; Gleason JL Angew Chem Int Ed Engl; 2004 Apr; 43(18):2432-6. PubMed ID: 15114583 [No Abstract] [Full Text] [Related]
2. Amplification of screening sensitivity through selective destruction: theory and screening of a library of carbonic anhydrase inhibitors. Cheeseman JD; Corbett AD; Shu R; Croteau J; Gleason JL; Kazlauskas RJ J Am Chem Soc; 2002 May; 124(20):5692-701. PubMed ID: 12010042 [TBL] [Abstract][Full Text] [Related]
3. Discovery of new chromone containing sulfonamides as potent inhibitors of bovine cytosolic carbonic anhydrase. al-Rashida M; Ashraf M; Hussain B; Nagra SA; Abbas G Bioorg Med Chem; 2011 Jun; 19(11):3367-71. PubMed ID: 21555223 [TBL] [Abstract][Full Text] [Related]
4. QSAR study on benzenesulphonamide carbonic anhydrase inhibitors: topological approach using Balaban index. Thakur A; Thakur M; Khadikar PV; Supuran CT; Sudele P Bioorg Med Chem; 2004 Feb; 12(4):789-93. PubMed ID: 14759739 [TBL] [Abstract][Full Text] [Related]
5. Fragment-based drug discovery of carbonic anhydrase II inhibitors by dynamic combinatorial chemistry utilizing alkene cross metathesis. Poulsen SA; Bornaghi LF Bioorg Med Chem; 2006 May; 14(10):3275-84. PubMed ID: 16431113 [TBL] [Abstract][Full Text] [Related]
6. In situ click chemistry: enzyme-generated inhibitors of carbonic anhydrase II. Mocharla VP; Colasson B; Lee LV; Röper S; Sharpless KB; Wong CH; Kolb HC Angew Chem Int Ed Engl; 2004 Dec; 44(1):116-20. PubMed ID: 15599912 [No Abstract] [Full Text] [Related]
7. Topological modeling of lipophilicity, diuretic activity, and carbonic inhibition activity of benzene sulfonamides: a molecular connectivity approach. Jaiswal M; Khadikar PV; Supuran CT Bioorg Med Chem Lett; 2004 Nov; 14(22):5661-6. PubMed ID: 15482943 [TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib. Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146 [TBL] [Abstract][Full Text] [Related]
9. QSAR study on carbonic anhydrase inhibitors: water-soluble sulfonamides incorporating beta-alanyl moieties, possessing long lasting-intra ocular pressure lowering properties--a molecular connectivity approach. Agrawal VK; Banerji M; Gupta M; Singh J; Khadikar PV; Supuran CT Eur J Med Chem; 2005 Oct; 40(10):1002-12. PubMed ID: 15961191 [TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bertucci A; Innocenti A; Zoccola D; Scozzafava A; Tambutté S; Supuran CT Bioorg Med Chem; 2009 Jul; 17(14):5054-8. PubMed ID: 19520577 [TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors. Inhibition of the Rv1284 and Rv3273 beta-carbonic anhydrases from Mycobacterium tuberculosis with diazenylbenzenesulfonamides. Maresca A; Carta F; Vullo D; Scozzafava A; Supuran CT Bioorg Med Chem Lett; 2009 Sep; 19(17):4929-32. PubMed ID: 19651511 [TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB. Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481 [TBL] [Abstract][Full Text] [Related]
13. QSAR studies for the inhibition of the transmembrane isozymes XII and XIV of human carbonic anhydrase with a series of sulfonamides. Tarko L; Supuran CT Bioorg Med Chem; 2007 Sep; 15(17):5666-71. PubMed ID: 17574422 [TBL] [Abstract][Full Text] [Related]
14. Designing of novel carbonic anhydrase inhibitors and activators. Supuran CT; Vullo D; Manole G; Casini A; Scozzafava A Curr Med Chem Cardiovasc Hematol Agents; 2004 Jan; 2(1):49-68. PubMed ID: 15328829 [TBL] [Abstract][Full Text] [Related]
15. An efficient strategy to enhance binding affinity and specificity of a known isozyme inhibitor. Jee JE; Lim J; Ong YS; Oon J; Gao L; Choi HS; Lee SS Org Biomol Chem; 2016 Jul; 14(28):6833-9. PubMed ID: 27339902 [TBL] [Abstract][Full Text] [Related]
16. QSAR study on para-substituted aromatic sulfonamides as carbonic anhydrase II inhibitors using topological information indices. Melagraki G; Afantitis A; Sarimveis H; Igglessi-Markopoulou O; Supuran CT Bioorg Med Chem; 2006 Feb; 14(4):1108-14. PubMed ID: 16213737 [TBL] [Abstract][Full Text] [Related]
17. Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates? De Simone G; Scozzafava A; Supuran CT Chem Biol Drug Des; 2009 Sep; 74(3):317-21. PubMed ID: 19703035 [TBL] [Abstract][Full Text] [Related]
18. A DFT-based quantum theoretic QSAR study of aromatic and heterocyclic sulfonamides as carbonic anhydrase inhibitors against isozyme, CA-II. Eroglu E; Türkmen H J Mol Graph Model; 2007 Nov; 26(4):701-8. PubMed ID: 17493855 [TBL] [Abstract][Full Text] [Related]
19. Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste. Köhler K; Hillebrecht A; Schulze Wischeler J; Innocenti A; Heine A; Supuran CT; Klebe G Angew Chem Int Ed Engl; 2007; 46(40):7697-9. PubMed ID: 17705204 [No Abstract] [Full Text] [Related]
20. S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. Lopez M; Paul B; Hofmann A; Morizzi J; Wu QK; Charman SA; Innocenti A; Vullo D; Supuran CT; Poulsen SA J Med Chem; 2009 Oct; 52(20):6421-32. PubMed ID: 19827837 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]